| # | Title | Journal | Year | Citations |
|---|
| 1 | PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project | Journal of Thoracic Oncology | 2017 | 1,067 |
| 2 | Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs | Proceedings of the National Academy of Sciences of the United States of America | 2015 | 376 |
| 3 | Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited | Cancer Discovery | 2021 | 169 |
| 4 | Transforming Cancer Prevention through Precision Medicine and Immune-oncology | Cancer Prevention Research | 2016 | 130 |
| 5 | Global progress against cancer-challenges and opportunities | Cancer Biology and Medicine | 2013 | 67 |
| 6 | Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker | Clinical Pharmacology and Therapeutics | 2016 | 57 |
| 7 | Disparities in Cancer Prevention in the COVID-19 Era | Cancer Prevention Research | 2020 | 54 |
| 8 | Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute | Cancer Research | 2017 | 52 |
| 9 | Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute | Ca-A Cancer Journal for Clinicians | 2017 | 49 |
| 10 | Characteristics and Outcome of AKT1E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry | Cancer Discovery | 2020 | 36 |
| 11 | AACR Cancer Disparities Progress Report 2022 | Cancer Epidemiology Biomarkers and Prevention | 2022 | 32 |
| 12 | [Letter to the Editor] The need for improved education and training in research antibody usage and validation practices | BioTechniques | 2016 | 30 |
| 13 | The art of translating nutritional science into dietary guidance: history and evolution of the Dietary Guidelines for Americans | Nutrition Reviews | 2011 | 29 |
| 14 | Putting PhDs to Work: Career Planning for Today's Scientist | CBE Life Sciences Education | 2014 | 29 |
| 15 | Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare | Blood Cancer Discovery | 2021 | 27 |
| 16 | Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies | JAMA Oncology | 2022 | 27 |
| 17 | AACR Project GENIE: 100,000 Cases and Beyond | Cancer Discovery | 2022 | 27 |
| 18 | AACR Cancer Disparities Progress Report 2020: Achieving the Bold Vision of Health Equity for Racial and Ethnic Minorities and Other Underserved Populations | Cancer Epidemiology Biomarkers and Prevention | 2020 | 26 |
| 19 | Design and analysis of group-randomized trials in cancer: A review of current practices | Preventive Medicine | 2018 | 21 |
| 20 | Genetically‐defined ovarian cancer mouse models | Journal of Pathology | 2016 | 20 |
| 21 | Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer | JAMA Network Open | 2021 | 20 |
| 22 | Annals of Internal Medicine at Age 75: Reflections on the Past 25 Years | Annals of Internal Medicine | 2002 | 13 |
| 23 | Accelerating the Delivery of Patient-Centered, High-Quality Cancer Care | Clinical Cancer Research | 2015 | 12 |
| 24 | The Landscape of Blood Cancer Research Today—and Where the Field Is Headed | Blood Cancer Discovery | 2020 | 11 |
| 25 | AACR Cancer Progress Report 2018: Harnessing Research Discoveries for Patient Benefit | Clinical Cancer Research | 2018 | 10 |
| 26 | How Did We Get a COVID-19 Vaccine in Less Than 1 Year? | Clinical Cancer Research | 2021 | 10 |
| 27 | AACR Cancer Progress Report 2021: Discovery Science Driving Clinical Breakthroughs | Clinical Cancer Research | 2021 | 9 |
| 28 | AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care | Clinical Cancer Research | 2022 | 9 |
| 29 | AACR Cancer Progress Report 2019: Transforming Lives Through Innovative Cancer Science | Clinical Cancer Research | 2019 | 8 |
| 30 | AACR Cancer Progress Report 2022: Decoding Cancer Complexity, Integrating Science, and Transforming Patient Outcomes | Clinical Cancer Research | 2022 | 8 |
| 31 | AACR Cancer Progress Report 2020: Turning Science into Lifesaving Care | Clinical Cancer Research | 2020 | 7 |
| 32 | Challenges to Using Big Data in Cancer | Cancer Research | 2023 | 7 |
| 33 | The National Cancer Institute R25 Cancer Education Grants Program: A Workshop Report | Journal of Cancer Education | 2017 | 6 |
| 34 | A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative Approach | JCO Clinical Cancer Informatics | 2022 | 5 |
| 35 | Introducing a New Series: Immunotherapy Facts and Hopes | Clinical Cancer Research | 2018 | 4 |
| 36 | FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs | Clinical Cancer Research | 2021 | 4 |
| 37 | A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop | Clinical Cancer Research | 2021 | 4 |
| 38 | Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers | Cancer Research | 2022 | 4 |
| 39 | Case Studies for Overcoming Challenges in Using Big Data in Cancer | Cancer Research | 2023 | 3 |
| 40 | Abstract 102: Clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS p.G12C-mutated metastatic non-small cell lung cancer (NSCLC) in the AACR Project GENIE database | Cancer Research | 2021 | 2 |
| 41 | Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology | Journal of Clinical Oncology | 2022 | 2 |
| 42 | Elotuzumab Promotes Self-Engagement of Signaling Lymphocytic Activation Molecule Family Member 7 (SLAMF7) Between Natural Killer (NK) and Multiple Myeloma (MM) Cells to Enhance Cytotoxicity | Clinical Lymphoma, Myeloma and Leukemia | 2018 | 1 |
| 43 | The 10th Annual Symposium on Global Cancer Research: New Models for Global Cancer Research, Training, and Control | JCO Global Oncology | 2022 | 1 |
| 44 | Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference | Cancer Immunology Research | 2023 | 1 |
| 45 | Her Imperial Highness Princess Takamatsu (1911-2004) | Cancer Science | 2005 | 0 |
| 46 | An Integrated Framework to Model Cellular Phenotype as a Component of Biochemical Networks | Advances in Bioinformatics | 2011 | 0 |
| 47 | Embracing change | Endocrine-Related Cancer | 2014 | 0 |
| 48 | Enrico Mihich, MD: In Memoriam (1928–2016) | Cancer Research | 2017 | 0 |
| 49 | Abstract 2620: Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates | | 2021 | 0 |
| 50 | Abstract 2619: Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data | | 2021 | 0 |
